We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Heplisav-B

News List

European CHMP Adopts Positive Opinion for HEPLISAV-B americanpharmaceuticalreview
January 05, 2021
Dynavax Technologies announced the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ...
European CHMP adopts positive opinion for Dynavax’s HEPLISAV-B vaccine for Hepatitis B pharmaceutical-business-review
December 15, 2020
Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ...
Dynavax Announces FDA Advisory Committee Vote in Favor of Heplisav-B drugs.com
August 01, 2017
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that the safety data for Heplisav-B...